Immunochemotherapy: The new standard in aggressive non-Hodgkin's lymphoma in the elderly
- 1 February 2003
- journal article
- review article
- Published by Elsevier in Seminars in Oncology
- Vol. 30 (1), 21-27
- https://doi.org/10.1053/sonc.2003.50021
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- CHOP is the standard regimen in patients > or = 70 years of age with intermediate-grade and high-grade non-Hodgkin's lymphoma: results of a randomized study of the European Organization for Research and Treatment of Cancer Lymphoma Cooperative Study Group.Journal of Clinical Oncology, 1998
- Effect of age on the characteristics and clinical behavior of non-Hodgkin's lymphoma patientsAnnals of Oncology, 1997
- A Clinical Evaluation of the International Lymphoma Study Group Classification of Non-Hodgkin's LymphomaBlood, 1997
- Treatment of aggressive Non‐Hodgkin's lymphoma in the elderlyAmerican Journal of Hematology, 1995
- What treatment for elderly patients with aggressive lymphoma?Annals of Oncology, 1994
- A Predictive Model for Aggressive Non-Hodgkin's LymphomaNew England Journal of Medicine, 1993
- Comparison of a Standard Regimen (CHOP) with Three Intensive Chemotherapy Regimens for Advanced Non-Hodgkin's LymphomaNew England Journal of Medicine, 1993
- Treatment of Non-Hodgkin's LymphomaNew England Journal of Medicine, 1993
- Aggressive Chemotherapy for Diffuse Histiocytic Lymphoma in the Elderly: Increased Complications with Advancing AgeJournal of the American Geriatrics Society, 1984
- ADVANCED DIFFUSE HISTIOCYTIC LYMPHOMA, A POTENTIALLY CURABLE DISEASEThe Lancet, 1975